Severin Schwan
Rejuvenated Roche has revealed record sales in the teeth of a recession. Its young 42-year-old CEO Severin Schwan has also masterminded its $47m takeover of biotech star Genentech. Schwan is investing in science, not short-term sales. Will it work?